K. K. Demirdöğen Et Al. , "Evaluation of Serum Death Receptor 4 and CCL5 Levels in Breast Cancer," 13th International Symposium on Pharmaceutical Sciences (ISOPS) , Ankara, Turkey, 2021
Demirdöğen, K. K. Et Al. 2021. Evaluation of Serum Death Receptor 4 and CCL5 Levels in Breast Cancer. 13th International Symposium on Pharmaceutical Sciences (ISOPS) , (Ankara, Turkey).
Demirdöğen, K. K., TAŞKAN, T., Noori, F., Karaman, N., KURUKAHVECİOĞLU, O., & GÖNENÇ, A., (2021). Evaluation of Serum Death Receptor 4 and CCL5 Levels in Breast Cancer . 13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey
Demirdöğen, Kader Et Al. "Evaluation of Serum Death Receptor 4 and CCL5 Levels in Breast Cancer," 13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 2021
Demirdöğen, Kader K. Et Al. "Evaluation of Serum Death Receptor 4 and CCL5 Levels in Breast Cancer." 13th International Symposium on Pharmaceutical Sciences (ISOPS) , Ankara, Turkey, 2021
Demirdöğen, K. K. Et Al. (2021) . "Evaluation of Serum Death Receptor 4 and CCL5 Levels in Breast Cancer." 13th International Symposium on Pharmaceutical Sciences (ISOPS) , Ankara, Turkey.
@conferencepaper{conferencepaper, author={Kader Kübra Demirdöğen Et Al. }, title={Evaluation of Serum Death Receptor 4 and CCL5 Levels in Breast Cancer}, congress name={13th International Symposium on Pharmaceutical Sciences (ISOPS)}, city={Ankara}, country={Turkey}, year={2021}}